VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q4 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 850 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | -50.0% | 850 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | -98.6% | 850 | -95.7% | 0.00% | -100.0% |
Q1 2018 | $139,000 | 0.0% | 19,567 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $139,000 | +414.8% | 19,567 | +339.7% | 0.01% | +500.0% |
Q3 2017 | $27,000 | -3.6% | 4,450 | -29.9% | 0.00% | 0.0% |
Q2 2017 | $28,000 | -49.1% | 6,350 | -36.5% | 0.00% | -50.0% |
Q1 2017 | $55,000 | -57.4% | 10,000 | -62.3% | 0.00% | -66.7% |
Q4 2016 | $129,000 | -20.4% | 26,550 | -14.4% | 0.01% | -25.0% |
Q3 2016 | $162,000 | -12.4% | 31,000 | -22.7% | 0.01% | -20.0% |
Q2 2016 | $185,000 | +302.2% | 40,100 | +360.9% | 0.01% | +233.3% |
Q4 2015 | $46,000 | – | 8,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |